Metals, metalloids, and cancer

Phytopharmaceuticals in Cancer Chemoprevention

Volumn , Issue , 2004, Pages 29-40

  Harris, Gabriel Keith ^a   Shi, Xianglin ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960103199     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (54)

1. Biehl, P.F., The Archaeology of Europe, in The International Encyclopedia of Social and Behavioral Sciences, Smelsar, N.J. and Balts, P.B., Eds. Elsevier Science, Oxford, 2002, pp. 4913.
2. Ziegler, E.E. and Filer, L.J., Eds., Present Knowledge in Nutrition, ILSI Press, Washington, DC, 1996.
3. Anonymous, Poisoning in history, JAMA, 287, 1500, 2002.
4. Gonzalez-Reimers, E. et al., Bone cadmium and lead in prehistoric inhabitants and domestic animals from Gran Canaria, Sci. Total Environ., 301, 97, 2003.
5. Lewis, R.J., Hawley’s Condensed Chemical Dictionary, John Wiley & Sons, New York, 1997.
6. Langard, S., One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports, Am. J. Ind. Med., 17, 189, 1990.
7. Clemens, F. and Landolph, J.R., Genotoxicity of samples of nickel refinery dust, Toxicol. Sci., 25, 25, 2003.
8. EPA, Health Assessment Document for Cadmium, U.S. Environmental Protection Agency, Washington, DC, 1981.
9. EPA, Evaluation of the Potential Carcinogenicity of Lead and Lead Compounds, U.S. Environmental Protection Agency, Washington, DC, 1989a.
10. IARC, Monograph on the Evaluation of Carcinogenicity: an Update of IARC Monographs, Vol. 1-42, Suppl. 7, World Health Organization, International Agency for Research on Cancer, Lyon, France, 1987.
11. NTP, National Toxicology Program Report on Carcinogens, Public Health Service, U.S. Department of Health and Human Services, Washington, DC, 2002.
12. Fu, H. and Boffetta, P., Cancer and occupational exposure to inorganic lead compounds: a metaanalysis of published data, Occup. Environ. Med., 52, 73, 1995.
13. Steenland, K. et al., Review of occupational lung carcinogens, Am. J. Ind. Med., 29, 474, 1996.
14. Tuchsen, F. et al., Incidence of lung cancer among cobalt-exposed women, Scand. J. Work Environ. Health, 22, 444, 1996.
15. Agudo, A. et al., Lung cancer and cigarette smoking in women: a multicenter case-control study in Europe, Int. J. Cancer, 88, 820, 2000.
16. Goyer, R.A. and Clarksen, T.W., Toxic effects of metals, in Casarett and O’Doul’s Toxicology: the Basic Science of Poisons, 5th ed., Klaassen, C.D., Ed., McGraw-Hill, New York, 1996.
17. Mahata, J. et al., Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India, Mutat. Res., 534, 133, 2003.
18. Smith, A.H. et al., Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water, Am. J. Epidemiol., 147, 660, 1998.
19. Wicks, M.J. et al., Arsenic exposure in a copper smelter as related to histological type of lung cancer, Am. J. Ind. Med., 2, 25, 1981.
20. Waxman, S. and Anderson, K.C., History of the development of arsenic derivatives in cancer therapy, Oncologist, 6, 3, 2001.
21. EPA, Integrated Risk Information System on Beryllium, U.S. Environmental Protection Agency, Washington, DC, 1999.
22. IARC, IARC Monographs on the Evaluation of the Carcinogenic Risk to Humans: Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry, Vol. 58, World Health Organization, International Agency for Research on Cancer, Lyon, France, 1994.
23. Steenland, K. and Ward, E., Lung cancer incidence among patients with beryllium disease: a cohort mortality study, J. Natl. Cancer Inst., 83, 1380, 1991.
24. Ward, E. et al., A mortality study of workers at seven beryllium processing plants, Am. J. Ind. Med., 22, 885, 1992.
25. McGavran, P.D., Rood, A.S., and Till, J.E., Chronic beryllium disease and cancer risk estimates with uncertainty for beryllium released to the air from the Rocky Flats Plant, Environ. Health Perspect., 107, 731, 1999.
26. Jin, T., Lu, J., and Nordberg, M., Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein, Neurotoxicology, 19, 529, 1998.
27. Waalkes, M.P., Cadmium carcinogenesis in review, J. Inorg. Biochem., 79, 241, 2000.
28. Ades, A.E. and Kazantzis, G., Lung cancer in a non-ferrous smelter: the role of cadmium, Br. J. Ind. Med., 45, 435, 1988.
29. Stohs, S.J. et al., Oxidative mechanisms in the toxicity of chromium and cadmium ions, J. Environ. Pathol. Toxicol. Oncol., 20, 77, 2001.
30. Shi, X. et al., Reduction of chromium (VI) and its relationship to carcinogenesis, J. Toxicol. Environ. Health B Crit. Rev., 2, 87, 1999.
31. Neuberger, J.S. and Hollowell, J.G., Lung cancer excess in an abandoned lead-zinc mining and smelting area, Sci. Total Environ., 25, 287, 1982.
32. Sheffet, A. et al., Cancer mortality in a pigment plant utilizing lead and zinc chromates, Arch. Environ. Health, 37, 44, 1982.
33. Steenland, K. and Boffetta, P., Lead and cancer in humans: where are we now?, Am. J. Ind. Med., 38, 295, 2000.
34. Tatrai, E. et al., Comparative in vitro toxicity of cadmium and lead on redox cycling in type II pneumocytes, J. Appl. Toxicol., 21, 479, 2001.
35. Norseth, T., Cancer hazards caused by nickel and chromium exposure, J. Toxicol. Environ. Health, 6, 1219, 1980.
36. Costa, M. et al., Phagocytosis, cellular distribution, and carcinogenic activity of particulate nickel compounds in tissue culture, Cancer Res., 41, 2868, 1981.
37. Kasprzak, K.S., Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis, Free Radical Biol. Med., 32, 958, 2002.
38. Blanc, J.F., Bioulac-Sage, P., and Balabaud, C., Iron overload and cancer, Bull. Acad. Natl. Med., 184, 355, 2000.
39. Kawanishi, S., Inoue, S., and Yamamoto, K., Site-specific DNA damage induced by nickel(II) ion in the presence of hydrogen peroxide, Carcinogenesis, 10, 2231, 1989.
40. Xu, J. et al., Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle, Carcinogenesis, 17, 1511, 1996.
41. Costa, M., Molecular targets of nickel and chromium in human and experimental systems, Scand. J. Work Environ. Health, 19, 71, 1993.
42. Hartwig, A. and Schwerdtle, T., Interactions by carcinogenic metal compounds with DNA repair processes: toxicological implications, Toxicol. Lett., 127, 47, 2002.
43. Hartwig, A. et al., Interference by toxic metal ions with zinc-dependent proteins involved in maintaining genomic stability, Food Chem. Toxicol., 40, 1179, 2002.
44. Haliwell, B. and Gutteridge, J.M.C., Free Radicals in Biology and Medicine, Oxford University Press, Oxford, 2000.
45. Halpern, H.J. et al., In situ detection, by spin trapping, of hydroxyl radical markers produced from ionizing radiation in the tumor of a living mouse, Proc. Natl. Acad. Sci. USA, 92, 796, 1995.
46. Jadhav, S.J., Nimbalkar, S.S., Kulkarni, A.D., and Madhavi, D.L., Lipid oxidation in biological and food systems, in Food Antioxidants: Technological, Toxicological, and Health Perspectives, Madhavi, D.L., D., S.S., and Salunkhe, D.K., Eds., Marcel Dekker, New York, 1996.
47. Dubin, M. and Stoppani, A.O., Programmed cell death and apoptosis: the role of mitochondria, Medicina, 60, 375, 2000.
48. Kolanjiappan, K., Manoharan, S., and Kayalvizhi, M., Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients, Clin. Chim. Acta, 326, 143, 2002.
49. Chen, F. et al., Cell apoptosis induced by carcinogenic metals, Mol. Cell. Biochem., 222, 183, 2001.
50. Pernin, D. et al., p53 Activation by PI-3K family kinases after DNA double-strand breaks, Bull. Cancer, 87, 635, 2000.
51. Meplan, C., Richard, M.J., and Hainaut, P., Redox signalling and transition metals in the control of the p53 pathway, Biochem. Pharmacol., 59, 25, 2000.
52. Chen, F. et al., Opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53- independent GADD45 induction by arsenite, J. Biol. Chem., 276, 11414, 2001.
53. Chen, F. et al., Carcinogenic metals and NF-kappaB activation, Mol. Cell. Biochem., 222, 159, 2001.
54. Chen, F. and Shi, X., Signaling from toxic metals to NF-kappaB and beyond: not just a matter of reactive oxygen species, Environ. Health Perspect., 110 (Suppl. 5), 807, 2002.